MedDataX Logo

Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants

NCT ID: NCT00757224

Last Updated: 2008-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants.

Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mothers who are in Maternity ward following birth will fill a questionnaire regarding smoking habits. Parents will be divided into non-smokers and smokers. Half of the smoking mothers will receive guidance regarding the association between parents smoking and respiratory diseases in the infant. They will also get ideas on how to reduce smoke exposure by their infant. 3 months and 1 year later all parents will be contacted by phone and asked about their children's health.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Smoke Pollution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-smoking

Group Type NO_INTERVENTION

No interventions assigned to this group

smoking parents A

Group Type NO_INTERVENTION

No interventions assigned to this group

smoking parents B

Parents will be educated on the hazards of passive smoke exposure and ways to reduce it

Group Type EXPERIMENTAL

Guidance

Intervention Type BEHAVIORAL

Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guidance

Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants born at Asaf Harofeh Medical Center
* Infants born at \>35W gestational age

Exclusion Criteria

* Infants requiring any supportive treatment (supplemental O2, fluids, glucose, antibiotics)
Minimum Eligible Age

1 Day

Maximum Eligible Age

3 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assaf-Harofeh Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

The institute of allergy and pulmonary medicine, Asaf Harofeh Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asaf Harofeh Medical Center

Ẕerifin, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arnon Elizur, MD

Role: CONTACT

Phone: 972-8-9779817

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arnon Elizur, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

147/08

Identifier Type: -

Identifier Source: org_study_id